Short APLS slightly under 40.38, target 29.78, stop loss @ 40.5 Check the time stamp on this data. Updated AI-Generated Signals for Apellis Pharmaceuticals Inc. (APLS) available here: APLS.

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In this article, we are going to ...

In this article, we are going to take a look at where Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stands against the other mid-cap healthcare stocks. According to projections by ReportLinker ...

Projected records are based on the PER of the players in each team’s post-trade rotation. Taking into account the players traded and the ability of their replacements, it is possible for each ...

Investors in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2020 ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $78.47, ...

Mizuho Securities analyst Graig Suvannavejh maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report) on September 13. The company’s shares closed last Friday at $37.62.

Below is Validea's guru fundamental report for APELLIS PHARMACEUTICALS INC (APLS). Of the 22 guru strategies we follow, APLS rates highest using our P/B Growth Investor model based on the ...

In this article, we are going to take a look at where Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stands against the ... as data shows that 15% of these stocks trade below their net cash value ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...